Edition:
United States

Aetna Inc (AET)

AET on New York Consolidated

155.69USD
26 Jul 2017
Change (% chg)

$-0.56 (-0.36%)
Prev Close
$156.25
Open
$155.74
Day's High
$156.52
Day's Low
$155.15
Volume
2,152,412
Avg. Vol
2,221,959
52-wk High
$157.55
52-wk Low
$104.59

AET

Chart for AET

About

Aetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health,... (more)

Overall

Beta: 0.53
Market Cap(Mil.): $51,828.13
Shares Outstanding(Mil.): 331.70
Dividend: 0.50
Yield (%): 1.28

Financials

  AET Industry Sector
P/E (TTM): 48.49 25.00 15.59
EPS (TTM): 3.22 -- --
ROI: -- 0.01 -8.43
ROE: 7.42 15.04 -8.00

Republican strategy on U.S. healthcare bill in flux ahead of vote

WASHINGTON U.S. Republican Senate leaders aim to hold a procedural vote as early as Tuesday to take up legislation to repeal or replace Obamacare, but it remained unclear which version of the bill senators would vote on.

Jul 24 2017

RPT-Republican strategy on U.S. healthcare bill in flux ahead of vote

WASHINGTON, July 23 U.S. Republican Senate leaders aim to hold a procedural vote as early as Tuesday to take up legislation to repeal or replace Obamacare, but it remained unclear which version of the bill senators would vote on.

Jul 23 2017

Republicans meet late into night as Trump demands new U.S. healthcare plan

WASHINGTON Republicans struggling to agree on healthcare legislation to overhaul Obamacare obeyed U.S. President Donald Trump's orders to try to swiftly reach a deal but were unable to resolve their differences in a long, late-night meeting. | Video

Jul 20 2017

UPDATE 11-Republicans meet late into night as Trump demands new U.S. healthcare plan

* Vote to open repeal debate next week (Updates with Republican meeting; adds Senator Corker on McCain)

Jul 19 2017

EMERGING MARKETS-Mexico peso hits 14-month high, Brazil real firms sharply

(Updates prices) By Bruno Federowski SAO PAULO, July 18 Mexico's peso hit a more than 14-month high on Tuesday and Brazil's real firmed sharply after the collapse of a key U.S. healthcare bill fostered doubts about President Donald Trump's economic plans and broadly weighed on the dollar. Trump's promises to cut taxes and boost spending has triggered expectations of faster inflation that could force the Federal Reserve to raise interest rates more than expected, potenti

Jul 18 2017

TREASURIES-Yields drop on U.S. healthcare concerns, weak data

* Republican push to overhaul or repeal healthcare law hits snag

Jul 18 2017

EMERGING MARKETS-LatAm currencies strengthen on U.S. healthcare bill collapse

By Bruno Federowski SAO PAULO, July 18 Latin American currencies strengthened on Tuesday after the collapse of a key U.S. healthcare bill fostered doubts about President Donald Trump's plans to lift the economy. Trump's promises to cut taxes and boost spending has triggered expectations of faster inflation that could force the U.S. Federal Reserve to raise interest rates more than expected, potentially draining capital from emerging markets. Trader skepticism over Tru

Jul 18 2017

TREASURIES-Yields slide as latest U.S. healthcare issue weighs

NEW YORK, July 18 U.S. Treasury yields fell on Tuesday, as investors grew cautious about the latest political drama in Washington around healthcare legislation and more data pointed to benign inflation with a drop in import prices for a second straight month.

Jul 18 2017

German stocks - Factors to watch on July 18

FRANKFURT, July 18 The following are some of the factors that may move German stocks on Tuesday:

Jul 18 2017

BRIEF-GSK begins shipping quadrivalent vaccine doses to U.S. healthcare providers

* Glaxosmithkline Plc says begun shipping quadrivalent vaccine doses to U.S. healthcare providers

Jul 14 2017

Competitors

  Price Chg
Anthem Inc (ANTM.N) $184.99 -5.59
CIGNA Corporation (CI.N) $173.57 -0.24

Earnings vs. Estimates